UBS Group’s Xtant Medical Holdings XTNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1 Hold
1
﹤0.01% 8870
2025
Q1
$0 Hold
1
﹤0.01% 9291
2024
Q4
$0 Sell
1
-39,047
-100% ﹤0.01% 9104
2024
Q3
$26.4K Buy
39,048
+31,239
+400% +$21.1K ﹤0.01% 5987
2024
Q2
$4.92K Sell
7,809
-634
-8% -$399 ﹤0.01% 6881
2024
Q1
$9.88K Buy
8,443
+8,351
+9,077% +$9.77K ﹤0.01% 6090
2023
Q4
$104 Sell
92
-4,127
-98% -$4.67K ﹤0.01% 7713
2023
Q3
$4.64K Buy
+4,219
New +$4.64K ﹤0.01% 6285
2023
Q2
Sell
-7,063
Closed -$4.5K 8494
2023
Q1
$4.5K Buy
7,063
+5,712
+423% +$3.64K ﹤0.01% 7082
2022
Q4
$892 Buy
+1,351
New +$892 ﹤0.01% 8843
2022
Q3
Sell
-4,888
Closed -$3K 9759
2022
Q2
$3K Buy
+4,888
New +$3K ﹤0.01% 8334
2022
Q1
Sell
-44,720
Closed -$25K 9674
2021
Q4
$25K Buy
+44,720
New +$25K ﹤0.01% 6482
2021
Q1
Sell
-1,262
Closed -$2K 8278
2020
Q4
$2K Buy
+1,262
New +$2K ﹤0.01% 7093
2020
Q3
Sell
-1,174
Closed -$1K 7424
2020
Q2
$1K Sell
1,174
-9,914
-89% -$8.45K ﹤0.01% 6947
2020
Q1
$7K Buy
+11,088
New +$7K ﹤0.01% 6247
2019
Q1
Sell
-1,887
Closed -$3K 7157
2018
Q4
$3K Buy
1,887
+1,159
+159% +$1.84K ﹤0.01% 6806
2018
Q3
$3K Sell
728
-7,724
-91% -$31.8K ﹤0.01% 6743
2018
Q2
$47K Buy
8,452
+4,611
+120% +$25.6K ﹤0.01% 5120
2018
Q1
$30K Sell
3,841
-1,826
-32% -$14.3K ﹤0.01% 5229
2017
Q4
$39K Sell
5,667
-1,583
-22% -$10.9K ﹤0.01% 5087
2017
Q3
$63K Sell
7,250
-1,009
-12% -$8.77K ﹤0.01% 4752
2017
Q2
$65K Sell
8,259
-979
-11% -$7.71K ﹤0.01% 4570
2017
Q1
$69K Buy
9,238
+1,298
+16% +$9.7K ﹤0.01% 4414
2016
Q4
$53K Buy
7,940
+4,857
+158% +$32.4K ﹤0.01% 4879
2016
Q3
$42K Sell
3,083
-457
-13% -$6.23K ﹤0.01% 4791
2016
Q2
$81K Buy
3,540
+3,349
+1,753% +$76.6K ﹤0.01% 4347
2016
Q1
$6K Sell
191
-11
-5% -$346 ﹤0.01% 6076
2015
Q4
$7K Buy
+202
New +$7K ﹤0.01% 6198
2015
Q2
Sell
-9
Closed 6909
2015
Q1
$0 Sell
9
-151
-94% ﹤0.01% 6816
2014
Q4
$6K Buy
+160
New +$6K ﹤0.01% 6274